Gatifloxacin
规格
112811-59-3CAS 号
664-293-2EC 号
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acidIUPAC 名称
C19H22FN3O4化学式
375.4 g/mol分子量
Gatifloxacin; 112811-59-3; Tequin; Gatiflo; Zymar; AM-1155; Gatifloxacine; Zymaxid; Zymer; gatifloxacin anhydrous; AM 1155; 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-; gatifloxacino; DTXSID5045704; 1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; gatifloxacinum; PD-135432; NSC-758701; CHEBI:5280; BMS-206584-01; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; 81485Y3A9A; Gatifloxacin (sesquihydrate); (+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; DTXCID3025704; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid; BMS-20658401; BMS206584; BMS 206584; RefChem:142731; J01MA16; S01AE06; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-4-ium-1-yl)-4-oxoquinoline-3-carboxylate; L4618BD7KJ; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; CG 5501; BMS-206584; GTFX; MFCD00895399; 160738-57-8; Gatifloxacin (INN); CHEMBL31; gatifloxin; Gatilox; Gatiquin; Gatispan; Gaity; 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; NCGC00068236-02; Tymer; GATIFLOXACIN [INN]; 1-Cyclopropyl-6-fluoro-8-methoxy-1,4-dihydro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylicacid; Gatifloxacin [USAN:INN]; Bonoq; BMS 206584-01; PD 135432; (+/-)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid; SMR000043336; CAS-112811-59-3; Zymer (TN); SR-01000610458; CG-5501; Gatifloxcin; Tequin in dextrose 5% in plastic container; AM-1155 (*Sesquihydrate*); Gatifloxacin & Gamma Interferon; UNII-81485Y3A9A; Kinome_3137; Spectrum_001909; CPD000043336; Gatifloxacin (Standard); Spectrum2_000487; Spectrum3_000999; Spectrum4_001127; Spectrum5_001468; GATIFLOXACIN [MI]; Epitope ID:540297; SCHEMBL22591; BSPBio_002697; KBioGR_001613; KBioSS_002448; MLS000040259; MLS000759493; MLS006011836; GATIFLOXACIN [WHO-DD]; SPECTRUM1504272; SPBio_000353; orb1309089; orb3025506; SCHEMBL29356306; Gatifloxacin - Bio-X trade mark; GTPL10816; KBio2_002442; KBio2_005010; KBio2_007578; KBio3_001917; MSK5720; GLXC-22553; HMS1922J15; HMS2090K10; HMS2093G06; HMS2233D20; HMS3259P06; HMS3372J10; HMS3372J12; HMS3715N03; HMS5079D13; Pharmakon1600-01504272; ALBB-028535; RKL10068; Tox21_110984; AM1155; BBL010485; BDBM50117914; CCG-39529; CG5501; EBC-11236; HB3263; HY-10581R; MSK5720-100M; NSC758701; s1340; STK801620; AKOS004119932; AKOS016340697; Tox21_110984_1; AC-1944; AC23649; CS-1841; DB01044; KS-1066; NC00702; NSC 758701; NCGC00068236-03; NCGC00068236-04; NCGC00068236-05; NCGC00068236-06; NCGC00068236-07; NCGC00068236-08; NCGC00095126-01; NCGC00095126-02; NCGC00178525-01; BG300001; Gatifloxacin 100 |Ig/mL in Acetonitrile; HY-10581; SY070194; SBI-0206764.P001; DB-019145; Gatifloxacin 100 microg/mL in Acetonitrile; G0325; Gatifloxacin Solution in Methanol, 100ug/mL; NS00004983; C07661; D08011; AB00171654-13; AB00171654-14; AB00171654_16; AB00171654_17; EN300-19768783; Q2365016; SR-01000610458-2; SR-01000610458-3; BRD-A74980173-001-02-8; BRD-A74980173-001-06-9; BRD-A74980173-001-11-9; BRD-A74980173-213-01-1; Z1824566854; ( inverted exclamation markA)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid sesquihydrate; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazino)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid; 1-cyclopropyl-7-(3-methyl-1-piperazinyl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid同义词
含有Gatifloxacin的产品
Gatifloxacin - Signa S.A. de C.V.Gatifloxacin - Hengdian GroupGatifloxacin - Aragen Life SciencesGatifloxacin - Hetero DrugsGatifloxacin - ViatrisGatifloxacin - Dr. Reddy's LaboratoriesGatifloxacin - Aurobindo Pharma LimitedGatifloxacin - Lupin LtdGatifloxacin - Hospira, Inc.Gatifloxacin - Aarti DrugsGatifloxacin - UnipexGatifloxacin - Matrix Pharmaceutical Inc
第 1/2 页
销售Gatifloxacin的公司
AP
Aurobindo Pharma LimitedIndiaDR
Dr. Reddy's LaboratoriesIndiaHI
Hospira, Inc.United StatesHD
Hangzhou Dingyan Chem Co., LtdChinaSI
Sinoway Industrial Co.Ltd.ChinaHB
Hubei Biocause Heilen Pharmaceutical Co.,LtdChina第 1/2 页